Goldman Sachs says this under-the-radar biotech play could more than double in value

Goldman Sachs says this under-the-radar biotech play could more than double in value

Goldman Sachs believes that Biohaven offers investors an under-the-radar opportunity to invest in a potentially best-in-class kidney disease treatment. The bank initiated coverage on the biopharmaceutical company at a buy rating, setting a 12-month price target of $23. Shares of Biohaven have plunged 70% over the past 12 months and are down around 3% this…

Read More
Wall Street analysts like these stocks for long-term growth potential

Wall Street analysts like these stocks for long-term growth potential

The latest earnings reports from major technology companies have revived investors’ concerns about payoffs on elevated artificial intelligence (AI) spending. While some companies failed to impress investors, others proved their ability to capitalize on solid growth opportunities offered by the ongoing AI boom. With their expertise and in-depth analysis, top Wall Street analysts can help…

Read More
Tech giants in China sold off alongside their U.S. peers. How to play it

Tech giants in China sold off alongside their U.S. peers. How to play it

The latest tech sell-off underscores that it’s still a different game for investing in China versus the U.S. “The U.S. decline was primarily triggered by earnings miss[es] from some market leaders, but in China it was mainly sentiment spillover plus portfolio adjustment/rotation,” said Ding Wenjie, investment strategist for global capital investment at China Asset Management…

Read More
Fivespan brings amicable activism to Appian in a bid to build value

Fivespan brings amicable activism to Appian in a bid to build value

Company: Appian Corp. (APPN) Business: Appian provides business process management (BPM) solutions. Its products include BPM software, case management, mobile application development and platform-as-a-service. The company was founded by Matthew Calkins, Robert Kramer, Marc Wilson and Michael Beckley in 1999 and is headquartered in McLean, Va. Stock Market Value: $1.86B ($25.21 per share) Activist: Fivespan…

Read More